Navigation Links
Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications.

eart failure and myocardial infarction.

'We were pleased to note that both NSAID-associated GI complications and death have been decreasing since 1992, which we believe can be attributed to several factors: use of lower-dose NSAIDs; decreasing prevalence of H. pylori; increasing use of proton-pump inhibitors; and the introduction of NSAIDs with greater GI safety, such as coxibs,' said Dr. Wilcox. "However, healthcare providers and patients need to be aware of the risks associated with these drugs to develop the best plan for using NSAID therapy.'

The panel developed the following recommendations for healthcare providers to use when determining whether to prescribe NSAID treatment to their patients: Review the treatment indication and potential patient risk factors, both for GI and cardiovascular complications, and discuss potential cardiovascular risk factor modifications with their patients.

Prescribe lower-risk agents after conducting a risk-benefit analysis to determine the GI versus cardiovascular risks for each individual. Patients who are at greater risk of GI bleeding should receive NSAIDs with lower GI risks, such as nsNSAIDs; patients with a greater risk of cardiovascular events should not receive COX-2 inhibitors; and patients with known or a high risk of cardiovascular disease should receive low-dose aspirin.

Limit the duration and dosage of the prescribed NSAID and ask about and advise their patients on combination NSAID therapy. Treat patients with H. pylori infection prior to beginning NSAID therapy so as not to increase the risk of complicated ulcers.

Institute gastroprotection methods, such as misoprostol or proton pump inhibitors (PPIs), for patients at high-risk of GI complications.

"The association of NSAID use with lower-GI tract complications is important diagnostically and therapeutically," explained Dr. Wilcox. "A better understanding of risk factors for and mechanisms of
'"/>




Page: 1 2 3

Related medicine news :

1. Safeguarding anti-inflammatory users from ulcers
2. Cancer drugs in development nearly doubled since 1995
3. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
4. African HIV strains more resistant to anti HIV drugs
5. Right drugs drastically cut stroke risk
6. Relating heart protection and antihypertensive drugs
7. Enzyme may be target for obesity drugs
8. New HIV cases resist drugs
9. Relief to pregnant women using fertility drugs
10. AIDS drugs linked to heart attack risk
11. FDA debates status of decongestant drugs
Post Your Comments:
(Date:10/11/2008)... Barnett International, a division of ...d the release of The Form FDA 1572: A Reference Gu...rs. Designed for clinical investigators, clinical ...fessionals, and others involved in the clinical re...ide to address the Form FDA 1572-Statement of Inve...
(Date:10/10/2008)... to develop some form of disease by 20 years after...10 (HealthDay News) -- Liver transplant patients h...population, say researchers in Finland. , In a...r Transplantation , researchers investigated the c... recipients from Helsinki University Central Hospi...
(Date:10/10/2008)..., Wis., Oct. 10 /PRNewswire/ -- More than 600 new ...residential election. This is the,result of Aurora...hursday,Oct. 9, at all of the health care system,...f 658 people signed up to vote at the drives., Au... the Wisconsin,Government Accountability Board to ...
(Date:10/10/2008)... Upon the completion of a highly succe... CDM Media proudly announces their next business t...mation technology executives in healthcare. CDM Me...aunch May 10-12, 2009 at the Four Seasons Resort i...ulu, HI (PRWEB) October 11, 2008 -- Upon the compl...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2
... of trauma care are very few compared to other med...re would help in improving emergency treatments an... deaths caused by accidents//. More than 10,000 ...00,000 people are severely injured daily – mostly ...
...logy and Aging had found that less volume of white...ld age people is the cause of decline in brain act...ne in brain activity in the old people is not age ...e matter (frontal lobe) of the brain. Study found ...
...aunting India over the past decade. The problem is...as many as 459 AIDS related deaths over the past t...uring the period between January//, 2002 and Septe...d in the state. Furthermore, 641 persons were foun...
...he low life expectancy of Scottish people who have...west in United Kingdom where the countries average... years for women//. The low life expectancy of the...aid to be due to increased smoking and lack of exe...
Other Medicine News:Health News:Orissa found to be worst affected by the killer disease, AIDS 2
(Date:10/8/2008)... /PRNewswire-USNewswire/ -- The facts are,overwhel...AIDS in,sub-Saharan Africa. More than 35,000,000 w... already died of AIDS. The Foundation for Hospices...ing and their families,find compassion and relief ...ive partnering initiative links African hospices a...
(Date:10/8/2008)... to be Discontinued and Headcount to be Reduced, S...lio Review; Zanolimumab Program to be Discontinue... Employees, COPENHAGEN, Oc... GEN),announced today that it is discontinuing dev...n, as a result of a portfolio review and,assessmen...
(Date:10/8/2008)...RNewswire/ -- Vical Incorporated (Nasdaq: VICL ),... nonclinical data,demonstrating that the company,s...n DNA- and protein-based infectious disease vaccin...land, Pharm.D., Ph.D., Vical,s,Senior Vice Preside...oday,Wednesday, October 8, at the World Vaccine C...
(Date:10/7/2008)...y of new device for detecting polyps that can be ...RLANDO, Fla., Oct. 7 /- At the Americ...eeting in Orlando (ACG 2008), renowned,gastroenter...a,multi-institutional clinical study that evaluate...a new device that is designed to improve the abili...
Breaking Medicine Technology:In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Achieving CVIS Goals Webinar 13451 1Achieving CVIS Goals Webinar 13451 2Dana Foundation releases arts and cognition research 13448 1Dana Foundation releases arts and cognition research 13448 2Rare Gene Mutation Plays Role in Longevity 13445 1Rare Gene Mutation Plays Role in Longevity 13445 2Rare Gene Mutation Plays Role in Longevity 13445 3Argosy publishing launches The Visible Body 13442 1Argosy publishing launches The Visible Body 13442 2Argosy publishing launches The Visible Body 13442 3
...THERSBURG, Md., May 24, 2007 /PRNewswire-FirstCall...l announce results from the,Phase 1 trial of its p...e markets open tomorrow. A conference call and liv...omorrow to discuss,the results. , Conference Call ...y, May 25, 2007 at 8:30,a.m. Eastern Time via phon...
...IN, Texas--(BUSINESS WIRE)--May 29, 2007 - Introge...,s clinical,collaborators will report updated Phas...rapy product candidates at the upcoming,annual mee... (ASCO),in Chicago and the American Society of Gen...than ever, advancing pipeline of,first-in-class ca...
Other Medicine Technology:Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%.
Inductive demineralized bone matrix and conductive cancellous chips. DBM and cancellous chips will be free of foreign matter. Demineralized bone matrix particle size is 125 to 1000 . Cancellous chip
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue.
Dedicated ENT electromagnetic surgical navigation system. Value priced for comunity hospitals and surgical centers.
Medicine Products: